Ali Erhan EREN, Gökhan BAŞTÜRK, Alper AKÇALI, Müşerref OKTUN

Achromobacter Xylosoxidans’a Bağlı Akut Prostatit: Bir Olgu Sunumu

Achromobacter xylosoxidans üriner sistem enfeksiyonlarının nadir görülen bir nedenidir ve sıklıkla immunsüpresif tedavi alan hastalarda ortaya çıkar. Biz burada ürodinamik inceleme sonrası akut prostatit gelişen, idrar örneğinde üreme olan ve etken ajan olarak Achromobacter xylosoxidans saptanan bir olgu sunuyoruz

Anahtar Kelimeler:

Achromobacter xylosoxidans, akut prostatit

Achromobacter Xylosoxidans’a Bağlı Akut Prostatit: Bir Olgu Sunumu,

Achromobacter xylosoxidans is a rare cause of the urinary system infections and occurs usually in patients under immunosuppressive treatment. We present a case with acute prostatitis which result from urodynamic investigation, with positive urine culture caused by Achromobacter xylosoxidans

Keywords:

Achromobacter xylosoxidans, acute prostatite,

PDF

___

Weitkamp JH, Tang YW, Haas DW, Midha NK, Crowe JE Jr. Recurrent Achromobacter xylosoxidans bactere- mia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome. Clin Infect Dis 2000;31:1183-1187.
Yabuuchi E, Oyama A. Achromobacter xylosoxidans n. sp. From human ear discharge. Jpn J Microbiol 1971; 15:477-481.
Duggan JM, Goldstein SJ, Chenoweth CE, Kauffman CA, Bradley SF. Achromobacter xylosoxidans bacteraemia: report of 4 cases and review of the literature. Clin Infect Dis 1996;23:569-576.
Tena D, Carranza R, Barbera´ JR, et al. Outbreak of long-term intravascular catheter-related bacteraemia due to Achromobacter xylosoxidans subspecies xylosoxidans in a haemodialysis unit. Eur J Clin Microbiol Infect Dis 2005;24:727-732.
Reina J, Antich M, Siquier B, Alomar P. Nosocomial outbreak of Achromobacter xylosoxidans associated with a diagnostic contrast solution. J Clin Pathol 1988;41:920- 923.
Gahren-Hansen B, Alstrup P, Dessau R, et al. Outbreak of infection with Achromobacter xylosoxidans from contaminated intravascular pressure transducers. J Hosp Infect 1988;12:1-6.
Igra-Siegman Y, Chmel H, Cobbs C. Clinical and labora- tory characteristics of Achromobacter xylosoxidans infection. J Clin Microbiol 1980;11:141-145.
van Horn K, Gedris CA, Ahmed T, Wormser GP. Bacteraemia and urinary tract infection associated with CDC Group vd biovar 2. J Clin Microbiol 1989; 27:201- 202.
Sarı İ, Akar S, Atay T, Aslan G, Akkoç N. A Rare Cause of Lower Urinary Tract Infection in Behçet's Disease: Chronic Prostatitis Caused by Achromobacter xylosoxi- dans. Turkiye Klinikleri J Dermatol 2008;18:212-214.
Tena D, Gonza´ Lez-Praetorıus A, Pe´ Rez-Balsalobre M, Sancho O&Bısquert J. Urinary tract infection due to Achromobacter xylosoxidans: Report of 9 cases. Scandinavian Journal of Infectious Diseases, 2008; 40: 84-87.
Aisenberg G, Rolston KV, Safdar A. Bacteraemia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003). Cancer 2004;101:2134-2140.
Fass RJ, Barnishan J, Solomon MC, Ayers LW. In vitro activities of quinolones, b-lactams, tobramycin, and trimethoprim-sulfamethoxazole against non-fermenta- tive Gram-negative bacilli. J Clin Microbiol 1996;40: 1412-1418.
Senda K, Arakawa Y, Ichiyama S, et al. PCR detection of metallo-beta-lactamase gene (blaIMP) in Gram-nega- tive rods resistant to broadspectru beta-lactams. J Clin Microbiol 1996;34:2909-2913.
Saiman L, Chen Y, Gabriel PS, Knirsch C. Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. Antimicrob Agents Chemot- her 2002;46:1105-1107.